CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
The new JV will be located in Riyadh, Saudi Arabia, and operate under the name ‘Lifera Omics’.
- The new JV will be located in Riyadh, Saudi Arabia, and operate under the name ‘Lifera Omics’.
- Lifera Omics will build on this strength with an advanced laboratory and bioinformatics infrastructure, also leveraging the CENTOGENE Biodatabank.
- In addition, Lifera made an investment in CENTOGENE in the form of a mandatorily convertible loan with a total aggregate principal amount of $30 million.
- CENTOGENE and Lifera management will be presenting at the Global Healthspan Summit at the Four Seasons Hotel in Riyadh on November 30, 2023.